CSIMarket Company Name, Ticker, Customers, else..


Si bone inc   (NASDAQ: SIBN)
Other Ticker:  
 


 

Si bone inc

SIBN's Financial Statements and Analysis



Si bone inc narrowed first quarter of 2025 net loss per share of $-0.15 compare to net loss per share of $-0.27 recorded in the same quarter a year ago a decrease compare to $-0.10 realized in previous quarter.


first quarter of 2025
Earnings Per Share Revenues
$ -0.15 $  47 Mill
$+0.12     $+9M     +23.32 %



Si Bone Inc 's Revenue rose by 23.32 % in first quarter of 2025 (Mar 31 2025) year on year, to $47 million and declined by -6.19 % sequentially.


Si Bone Inc is

More on SIBN's Income Statement



Si Bone Inc in the first quarter of 2025 recorded net loss of $-6.542 million, an improvement compare to net loss of $-10.904 million in I. Quarter a year ago.

Sequentially net loss advanced

More on SIBN's Growth

Si Bone Inc Inventories
Inventories grew by 44.33 % to $30 million from I. Quarter a year ago, sequentially inventories rose by 12.21 %. SIBN's Cash flow In the first quarter of 2025 company's net cash flow was $6 million, capital expenditures grew by -2.082-0.48%, to $-2 millions compare to same quarter a year ago

More on SIBN's Cash flow Statement


Si bone inc does not pay out common stock dividend.

In trailing twelve-month period Si bone inc payed $ -0.23 cash per share, on a free-cash flow basis .

Book value fell by -2.47 % sequentially to $3.95 per share, -15.79% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.95 per share from $ 4.05.

Company issued 1.12 million shares or 2.72 % in Mar 31 2025.


• More on SIBN's Dividends

 Market Capitalization (Millions) 728
 Shares Outstanding (Millions) 42
 Total Debt (Millions $) 35
 Revenue (TTM) (Millions $) 176
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -10
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 344




Si bone inc does not pay out common stock dividend.

In trailing twelve-month period Si bone inc had negative $ -0.23 cash flow per share, on a free-cash flow basis .

Book value fell by -2.47 % sequentially to $3.95 per share, -15.79% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.95 per share from $ 4.05.

Company issued 1.12 million shares or 2.72 % in Mar 31 2025.


• More on SIBN's Balance Sheets

 Market Capitalization (Millions) 728
 Shares Outstanding (Millions) 42
 Total Debt (Millions $) 35
 Revenue (TTM) (Millions $) 176
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -10
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 344
   


  News about Si bone inc Earnings

Si Bone Inc. Achieves FDA Clearance for Enhanced iFuse Bedrock Granite Implant System, Including Pediatric Applications

Si Bone Inc., a renowned medical device company specialized in musculoskeletal disorders of the sacropelvic anatomy, has recently achieved FDA 510(k) clearance for its enhanced iFuse Bedrock Granite Implant System. This advanced system boasts a smaller diameter of 9.5 mm, rendering it more adaptable for usage in diverse anatomical conditions. Moreover, the clearance now encompasses an expanded indication for pediatric patients, as well as an extended application that encompasses the S1 trajectory.
The iFuse Bedrock Granite Implant System is designed to facilitate sacroiliac (SI) joint fusion and sacropelvic fixation when positioned across the SI joint. This implant assumes a foundational role in multi-se...

SI-BONE, Inc. Surpasses Expectations with Record-Breaking Financial Results

SI-BONE, Inc., a leading medical device company specializing in musculoskeletal disorders of the sacropelvic anatomy, has recently announced its financial results for the fourth quarter and full year ended December 31, 2023. The company reported an improvement in its earnings per share (EPS) compared to the previous year, with a decrease in loss per share from $-0.31 to $-0.24. Additionally, the company saw a sequential improvement in EPS from $-0.25 in the preceding financial reporting period.
One of the highlights of SI-BONE's financial performance was the significant increase in revenue. The company experienced a rapid revenue growth of 21.278%, with revenues reaching $38.75 million in the fourth quar...

Si Bone Inc Achieves Remarkable Revenue Growth in the Third Quarter of 2023, Fueling Optimism for Future Success

Si Bone In...

Si Bone Inc Surpasses Expectations with Remarkable Financial Turnaround in Q2 2023



Si Bone Inc, a leading Medical Equipment and Supplies company, has recently released its financial results for the second quarter of 2023. These results indicate several positive developments in terms of earnings, revenue, and stability. Analyzing these facts raises questions about how they will impact the company's future prospects.
1. Improved Earnings:
Si Bone Inc has successfully reduced its loss per share, demonstrating promising growth. Comparing the current loss per share of $-0.30 with $-0.54 from a year ago suggests the company is effectively managing its costs and improving profitability. This trend reflects the organization's ability to adapt and refine its operations in a highly...

The company disclosed a remarkable accomplishment, over the first quarter of 2023

Si Bone Inc, a leading me...


Date modified: 2025-05-07T13:38:32+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com